RTSM and clinical trial supply software for sponsors and CROs
4G Clinical builds randomization and trial supply management software (Prancer RTSM and 4C Supply) used to run clinical studies. Its stack mixes Django, Ruby on Rails with CoffeeScript, and Angular/Node.js, which points to a mature, multi-generation codebase. A heavy QA toolchain (Selenium, Playwright, WebdriverIO, Cucumber) fits validated, regulated software. Hiring is accelerating, led by engineering, with a notable push into demand generation and Japan.
4G Clinical is a privately held company founded in 2015 and headquartered in Wellesley, MA, with 201–500 employees. It develops RTSM (randomization and trial supply management) and clinical supply forecasting software for pharmaceutical sponsors and contract research organizations. Its products, Prancer RTSM and 4C Supply, support trials across phases and complexity levels. Each study is paired with RTSM specialists who advise on trial design and mid-study changes. The company is hiring in the United States and Japan.
4G Clinical uses Python with Django and Django REST Framework, Ruby on Rails, Angular, TypeScript, Node.js, and AWS with Docker. Testing runs on Selenium, Playwright, WebdriverIO and Cucumber, with Jenkins, Bamboo and Travis CI.
4G Clinical is hiring in the United States and Japan, with engineering as the largest focus alongside marketing, support, product and sales roles.
Current work centers on Prancer RTSM configuration and integration changes, project validation, high-availability application development, a growth marketing engine, and CRM-driven reporting dashboards.
Other companies in the same industry, closest in size
4G Clinical's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.